| Autor: |
Araujo-Neto AP; Laboratório de Genética e Biologia Molecular, Universidade Federal de Piauí, Parnaíba, PI, Brazil., Ferreira-Fernandes H; Laboratório de Genética e Biologia Molecular, Universidade Federal de Piauí, Parnaíba, PI, Brazil., Amaral CM; Departamento de Genética, Centro de Biociências, Universidade Federal de Pernambuco, Recife, PE, Brazil., Santos LG; Faculdade de Medicina, Universidade Federal do Piauí, Teresina, PI, Brazil., Freitas AC; Departamento de Genética, Centro de Biociências, Universidade Federal de Pernambuco, Recife, PE, Brazil., Silva-Neto JC; Departamento de Histologia e Embriologia, Centro de Biociências, Universidade Federal de Pernambuco, Recife, PE, Brazil., Rey JA; Molecular Oncogenetics Laboratory, Unidad de Investigación, Hospital Universitario La Paz, Madrid, Spain., Burbano RR; Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal de Pará, Belém, PA, Brazil., Silva BB; Faculdade de Medicina, Universidade Federal do Piauí, Teresina, PI, Brazil., Yoshioka FK; Laboratório de Genética e Biologia Molecular, Universidade Federal de Piauí, Parnaíba, PI, Brazil., Pinto GR; Laboratório de Genética e Biologia Molecular, Universidade Federal de Piauí, Parnaíba, PI, Brazil. |
| Abstrakt: |
Prostate cancer is the second most common cancer among men in western populations, and despite its high mortality, its etiology remains unknown. Inflammatory processes are related to the etiology of various types of tumors, and prostate inflammation, in particular, has been associated with prostate cancer carcinogenesis and progression. Human papillomavirus (HPV) is associated with benign and malignant lesions in the anogenital tract of both females and males. The possible role of HPV in prostate carcinogenesis is a subject of great controversy. In this study, we aimed to examine the prevalence of HPV infections in prostate carcinomas of patients from northeastern Brazil. This study included 104 tissue samples from primary prostate carcinoma cases. HPV DNA was purified and then amplified using MY09/11 and GP5+/GP6+ degenerate primer sets that detect a wide range of HPV types, and with specific PCR primers sets for E6 and E7 HPV regions to detect HPV 16. None of the samples showed amplification products of HPV DNA for primer sets MY09/11 and GP5+/GP6+, or the specific primer set for the E6 and E7 HPV regions. HPV infection, thus, does not seem to be one of the causes of prostate cancer in the population studied. |
